Metabolic and Bariatric Surgery for Obesity.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28193516.
- Also identified by DOI 10.1053/j.gastro.2017.01.051.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Metabolic and bariatric surgery (MBS) leads to weight loss in obese individuals and reduces comorbidities such as type 2 diabetes. MBS is superior to medical therapy in reducing hyperglycemia in persons with type 2 diabetes, and has been associated with reduced mortality and incidences of cardiovascular events and cancer in obese individuals. New guidelines have been proposed for the use of MBS in persons with type 2 diabetes. We review the use of MBS as a treatment for obesity and obesity-related conditions and, based on recent evidence, propose that health care systems make the appropriate changes to increase accessibility for eligible patients.
Medical subject headings
- Bariatric Surgery
- Diabetes Mellitus, Type 2
- Gastrointestinal Tract
- Obesity